Page last updated: 2024-08-23

bromocriptine and physostigmine

bromocriptine has been researched along with physostigmine in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19909 (39.13)18.7374
1990's6 (26.09)18.2507
2000's5 (21.74)29.6817
2010's2 (8.70)24.3611
2020's1 (4.35)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F1
Battista, AF; Goldstein, M; Miyamoto, T1
Carolei, A; Margotta, V; Palladini, G1
Inano, S; Kaneyuki, H; Mizuki, Y; Ukita, T; Ushijima, I; Yamada, M1
Jamshidzadeh, A; Zarrindast, MR1
Poddar, MK; Ray, SK1
Chee, KY; Sachdev, P1
Poursoltan, M; Zarrindast, MR1
Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M1
Mizuki, Y; Ushijima, I; Yamada, M1
Berger, PA; Stahl, SM1
Fincke, M; Gothóni, P; Lehtinen, M1
Ghosh, MN; Gopalakrishnan, V; Pillai, NP; Ramaswamy, S1
Ghazi-Khansari, M; Heidari, I; Zarrindast, MR1
Bani-Assadi, S; Ghazi-Khansari, M; Rezvani, N; Zarrindast, MR1
Kurasawa, M; Nakamura, K1
de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P1
Brown, J; Chan, BS; Downes, MA; Harris, K; Isoardi, KZ; Seebaluck, J1

Reviews

2 review(s) available for bromocriptine and physostigmine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pharmacotherapy of aphasia: myth or reality?
    Brain and language, 2007, Volume: 102, Issue:1

    Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem

2007

Trials

2 trial(s) available for bromocriptine and physostigmine

ArticleYear
Pharmacological characterization of tardive akathisia.
    Biological psychiatry, 1990, Nov-01, Volume: 28, Issue:9

    Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid

1990
Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
    Neurology, 1982, Volume: 32, Issue:8

    Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dystonia; Female; Haloperidol; Humans; Male; Middle Aged; Neurotransmitter Agents; Physostigmine; Receptors, Cholinergic; Receptors, Dopamine; Torticollis

1982

Other Studies

19 other study(ies) available for bromocriptine and physostigmine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Pharmacology of Huntington's chorea. Personal experience.
    European neurology, 1977, Volume: 16, Issue:1-6

    Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid

1977
Modification of involuntary movements by centrally acting drugs.
    Advances in neurology, 1975, Volume: 9

    Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline

1975
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
    Neuropsychobiology, 1975, Volume: 1, Issue:6

    Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria

1975
Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 43, Issue:3

    Topics: Animals; Behavior, Animal; Bromocriptine; Dilazep; Dopamine; Dopamine Agents; Injections, Intraperitoneal; Male; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Purines; Rats; Rats, Wistar; Yawning

1992
Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    British journal of pharmacology, 1992, Volume: 105, Issue:3

    Topics: Animals; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Physostigmine; Pilocarpine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Yawning

1992
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
    European journal of pharmacology, 1990, Jun-08, Volume: 181, Issue:3

    Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bromocriptine; Carbaryl; Corpus Striatum; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methysergide; Physostigmine; Rats; Serotonin; Tremor

1990
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    British journal of pharmacology, 1989, Volume: 96, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atropine; Behavior, Animal; Benzazepines; Bromocriptine; Drug Interactions; Male; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Theophylline; Yawning

1989
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1988, Volume: 8, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning

1988
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Psychopharmacology, 1988, Volume: 95, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning

1988
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
    Naunyn-Schmiedeberg's archives of pharmacology, 1983, Volume: 323, Issue:3

    Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor

1983
Effect of prolactin and bromocriptine on intestinal transit in mice.
    European journal of pharmacology, 1981, Sep-24, Volume: 74, Issue:4

    Topics: Animals; Bromocriptine; Drug Interactions; Female; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Morphine; Physostigmine; Prolactin

1981
Effects of lead exposure on bromocriptine-induced penile erection in rats.
    Pharmacology & toxicology, 1997, Volume: 81, Issue:2

    Topics: Animals; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Fresh Water; Injections, Intraperitoneal; Lead; Male; Organometallic Compounds; Parasympathomimetics; Penile Erection; Physostigmine; Rats; Rats, Wistar; Spectrophotometry, Atomic

1997
Effects of lead exposure on licking and yawning behaviour in rats.
    Pharmacology & toxicology, 1998, Volume: 83, Issue:3

    Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cholinesterase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Lead Poisoning; Male; Organometallic Compounds; Physostigmine; Poisons; Rats; Rats, Wistar; Yawning

1998
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
    European journal of pharmacology, 2001, May-18, Volume: 420, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological

2001
Case series profile of olanzapine post-injection delirium/sedation syndrome.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:2

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Delirium; Female; Humans; Male; Middle Aged; Olanzapine; Physostigmine; Rivastigmine

2023